Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Retained Earnings (2016 - 2025)

Ocular Therapeutix has reported Retained Earnings over the past 13 years, most recently at -$1.2 billion for Q4 2025.

  • Quarterly results put Retained Earnings at -$1.2 billion for Q4 2025, down 29.84% from a year ago — trailing twelve months through Dec 2025 was -$1.2 billion (down 29.84% YoY), and the annual figure for FY2025 was -$1.2 billion, down 29.84%.
  • Retained Earnings for Q4 2025 was -$1.2 billion at Ocular Therapeutix, down from -$1.1 billion in the prior quarter.
  • Over the last five years, Retained Earnings for OCUL hit a ceiling of -$536.1 million in Q1 2021 and a floor of -$1.2 billion in Q4 2025.
  • Median Retained Earnings over the past 5 years was -$668.1 million (2023), compared with a mean of -$736.6 million.
  • Peak annual rise in Retained Earnings hit 1.22% in 2021, while the deepest fall reached 32.34% in 2021.
  • Ocular Therapeutix's Retained Earnings stood at -$545.8 million in 2021, then decreased by 13.02% to -$616.8 million in 2022, then decreased by 13.09% to -$697.6 million in 2023, then decreased by 27.74% to -$891.1 million in 2024, then fell by 29.84% to -$1.2 billion in 2025.
  • The last three reported values for Retained Earnings were -$1.2 billion (Q4 2025), -$1.1 billion (Q3 2025), and -$1.0 billion (Q2 2025) per Business Quant data.